University of California, Irvine
Plastic Surgery residency · Orange, CA · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of California, Irvine's research in plastic surgery, which the program shares with other departments and affiliated hospitals.
Plastic Surgery at University of California, Irvineshared by every program there, not this program's own
Institution-level: all plastic surgery publications from University of California, Irvine and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Plastic Surgery research topics at University of California, Irvine
Papers in the window; each links to the list on OpenAlex.
Most cited at University of California, Irvine since 2024
All plastic surgery papers there on OpenAlex
- Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 studyDo‐Youn Oh et al. · The Lancet. Gastroenterology & hepatology · 2024 · PubMed · cited 325
- Hydrogel crosslinking modulates macrophages, fibroblasts, and their communication, during wound healingSergei Butenko et al. · Nature Communications · 2024 · PubMed · cited 230
- 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomitingJørn Herrstedt et al. · ESMO Open · 2024 · PubMed · cited 206
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)Brett King et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 116
- Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trialAndrea Necchi et al. · The Lancet Oncology · 2024 · PubMed · cited 105
- TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomesYohann Loriot et al. · Annals of Oncology · 2024 · PubMed · cited 98
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial ProgramBrett King et al. · American Journal of Clinical Dermatology · 2024 · PubMed · cited 73
- Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trialRoger Li et al. · Nature Medicine · 2024 · PubMed · cited 70
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia AreataBrett King et al. · JAMA Dermatology · 2024 · PubMed · cited 60
- Management of Gallstone PancreatitisJames McDermott et al. · JAMA Surgery · 2024 · PubMed · cited 50
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-california-irvine-plastics"><img src="https://openprograms.org/programs/university-california-irvine-plastics/badge.svg" alt="University of California, Irvine Plastic Surgery residency on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.